Sign In
Buy KVUE
$17.32
-0.0300 (-0.173%)
At Close: Jun 02, 2026
Kimberly-Clark: This 5% Yielder Is A Buy Ahead Of The Kenvue Merger
05:33pm, Monday, 20'th Apr 2026
I am upgrading Kimberly-Clark shares to a buy ahead of the planned Kenvue merger. The Kenvue deal offers significant cost synergies, enhanced bargaining power, and will position the entity as one of t
The Smartest Dividend Stocks to Buy With $2,000 Right Now
04:05pm, Sunday, 19'th Apr 2026
After its product lineup faced a long-lasting headwind, beverage outfit PepsiCo may finally be back on track. Johnson & Johnson spinoff Kenvue is built for reliable recurring income.
Brokerages Set Kenvue Inc. (NYSE:KVUE) Target Price at $19.50
01:44am, Friday, 17'th Apr 2026
Kenvue Inc. (NYSE: KVUE - Get Free Report) has been assigned an average rating of "Hold" from the sixteen research firms that are presently covering the stock, MarketBeat.com reports. Thirteen investm
Kimberly-Clark's New Structure Sets Stage for Kenvue Integration
10:10am, Thursday, 16'th Apr 2026
Kimberly-Clark's lean new regional structure is built for speed as it prepares to integrate Kenvue in a $48.7B deal closing in H2 2026.
Kimberly-Clark Details Structure, Leadership Team Following Kenvue Deal
10:01am, Wednesday, 15'th Apr 2026
The combined company, which will include consumer brands such as Kleenex tissues and Huggies diapers as well as over-the-counter products including Tylenol and Listerine, will operate under four geogr
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal
09:52am, Wednesday, 15'th Apr 2026
Kimberly-Clark on Wednesday said its chief financial officer, Nelson Urdaneta, will become the finance chief of the combined company it will create after completing its $40-billion acquisition o
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership
08:55am, Wednesday, 15'th Apr 2026
DALLAS, April 15, 2026 /PRNewswire/ -- Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leadership that will become effective upon completion of its pen
Tylenol in pregnancy not linked with autism, Danish study finds
02:09pm, Monday, 13'th Apr 2026
The use of Tylenol by women during pregnancy was not associated with autism in their children, according to results of a nationwide study in Denmark published on Monday.
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down
06:25am, Saturday, 11'th Apr 2026
Consumer staples lagged in 2025 and into this year, creating rare entry points for long-term income investors. Dividend durability remains strong in these four tickers despite short-term earnings pres
Alpha Omega Wealth Management LLC Sells 167,069 Shares of Kenvue Inc. $KVUE
03:20am, Friday, 10'th Apr 2026
Alpha Omega Wealth Management LLC decreased its position in Kenvue Inc. (NYSE: KVUE) by 53.9% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchang
Capricorn Fund Managers Ltd Takes $4.87 Million Position in Kenvue Inc. $KVUE
04:43am, Monday, 06'th Apr 2026
Capricorn Fund Managers Ltd bought a new position in Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
Contrasting Kenvue (NYSE:KVUE) & Tokyo Lifestyle (NASDAQ:TKLF)
01:09am, Monday, 06'th Apr 2026
Tokyo Lifestyle (NASDAQ: TKLF - Get Free Report) and Kenvue (NYSE: KVUE - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies based o
Here's Why Kenvue (KVUE) Could be Great Choice for a Bottom Fisher
10:55am, Wednesday, 01'st Apr 2026
Kenvue (KVUE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall St
Kenvue (NYSE:KVUE) vs. Synergy CHC (NASDAQ:SNYR) Head-To-Head Comparison
01:10am, Wednesday, 01'st Apr 2026
Synergy CHC (NASDAQ: SNYR - Get Free Report) and Kenvue (NYSE: KVUE - Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based
Analysts Set Kenvue Inc. (NYSE:KVUE) Price Target at $19.58
01:47am, Monday, 23'rd Mar 2026
Shares of Kenvue Inc. (NYSE: KVUE - Get Free Report) have been assigned a consensus recommendation of "Hold" from the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. T
